 Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores
Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores Bajaj Electricals Ltd consolidated Q2FY26 PAT at Rs. 9.86 crores
Bajaj Electricals Ltd consolidated Q2FY26 PAT at Rs. 9.86 crores Equitas Small Finance Bank Ltd posts PAT of Rs. 24.13 crores in Q2 FY2025-26
Equitas Small Finance Bank Ltd posts PAT of Rs. 24.13 crores in Q2 FY2025-26 Saint-Gobain Sekurit India Ltd posts Rs. 10.76 crores PAT in Q2FY26
Saint-Gobain Sekurit India Ltd posts Rs. 10.76 crores PAT in Q2FY26 Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores
Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores 
              (Rating: BUY, TP: Rs2,012, Upside: 15.7%)
- Polycab delivered better than expected revenue growth of 43%, with strong growth across its B2C product portfolio. Gross margins contracted by 519bps yoy on higher commodity prices. Cost control measures have restricted contraction of EBITDA margins.
- B2C business delivered strong growth with FMEG registering growth of 89%, highest among peers. Wires, which is a B2C business has sustained its growth momentum delivering superior growth.
- We estimate the company to deliver FY21-23E revenue/EBITDA CAGR of 15%/16% respectively. Considering a strong execution track record, 5-year vision plan and increasing proportion of B2C business, we increase our target multiple to 28x from earlier 25x and maintain BUY with TP of Rs2,012. Polycab still trades at a significant discount to players like Havells, Crompton which should continue to narrow gradually.